Cactus Acquisition Corp. 1 Ltd
Cash in trust
$652.0K
$652,000
Trust per share
$10.35
Redemption value
IPO
Nov 2021
$126.5M raised
Combination deadline
—
Not disclosed
Filings on record
173
Latest Sep 4, 2026
Overview
Cactus Acquisition Corp. 1 Ltd is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001865861. It completed its initial public offering in Nov 2021, raising $126.5M in gross proceeds. The vehicle is sponsored by Cactus Healthcare Management through Cactus Healthcare Management LP. The mandate targets technology, healthcare. Deadline lapsed without a deal; trust returned to public shareholders.
“we intend to focus our search on technology -based healthcare businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection.”
Reading the filings
Arithmetic on what Cactus Acquisition Corp. 1 Ltd has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trust versus the $10 unit
The trust holds $10.35 per public share, 3.5% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Underwriting
Oppenheimer led the offering. It has been named on 13 SPAC IPOs, book-running 12 of them, and 9.1% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
SEC filing history
Free tier: filings older than 24 hours- 10-Q
Quarterly report
Accession 0001493152-26-040661
- NT 10-Q
Late quarterly report notification
Accession 0001493152-26-038523
- 10-K
Annual report
Accession 0001493152-26-035259
- NT 10-K
Late annual report notification
Accession 0001493152-26-014660
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000902664-26-000987
- 8-K
Current report
Item 5.02 · Accession 0001493152-26-000441
- 425
Business-combination communication
Accession 0001493152-25-029422
- 10-Q
Quarterly report
Accession 0001493152-25-024332
- NT 10-Q
Late quarterly report notification
Accession 0001493152-25-023924
- 8-K
Submission of matters to a vote of security holders; Other events
Items 5.07, 8.01, 9.01 · Accession 0001493152-25-021107
- DEF 14A
Definitive proxy statement
Accession 0001493152-25-018836
- PRE 14A
PRE 14A
Accession 0001641172-25-026745
- 10-Q
Quarterly report
Accession 0001641172-25-023964
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000902664-25-003527
- 10-Q
Quarterly report
Accession 0001641172-25-022944
- 8-K
Current report
Item 5.02 · Accession 0001641172-25-015783
- NT 10-Q
Late quarterly report notification
Accession 0001641172-25-011122
- 10-K
Annual report
Accession 0001641172-25-004835
- NT 10-K
Late annual report notification
Accession 0001641172-25-001693
- 25-NSE
Notification of delisting
Accession 0001354457-25-000222
- 8-K
Current report
Item 5.02 · Accession 0001493152-24-049218
- 10-Q
Quarterly report
Accession 0001437749-24-035486
- SC 13G/A
683 CAPITAL MANAGEMENT, LLC
Accession 0001085146-24-005984
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001398344-24-020930
- NT 10-Q
Late quarterly report notification
Accession 0001437749-24-035291
- 425
Business-combination communication
Accession 0001437749-24-033973
- 8-K
Submission of matters to a vote of security holders; Other events
Items 5.07, 8.01, 9.01 · Accession 0001437749-24-033972
- 8-K
Notice of delisting or failure to satisfy a listing rule
Items 3.01, 9.01 · Accession 0001437749-24-033165
- DEFA14A
Additional proxy soliciting material
Accession 0001437749-24-032746
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001437749-24-032745
Pro
1 filing from the last 24 hours are hidden
Pro accounts see every filing minutes after EDGAR publishes it, instead of a day later.
Cancel any time. Billed monthly in USD.
Cactus Acquisition Corp. 1 Ltd: questions answered
What is Cactus Acquisition Corp. 1 Ltd?
Cactus Acquisition Corp. 1 Ltd is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001865861. It completed its initial public offering in Nov 2021, raising $126.5M in gross proceeds. The vehicle is sponsored by Cactus Healthcare Management through Cactus Healthcare Management LP. The mandate targets technology, healthcare. Deadline lapsed without a deal; trust returned to public shareholders.
How much does Cactus Acquisition Corp. 1 Ltd hold in trust?
Approximately $652,000, or about $10.35 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Cactus Acquisition Corp. 1 Ltd complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Cactus Acquisition Corp. 1 Ltd does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Cactus Acquisition Corp. 1 Ltd, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.35 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Cactus Acquisition Corp. 1 Ltd?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
Who sponsors Cactus Acquisition Corp. 1 Ltd, and what is their track record?
Cactus Healthcare Management LP is the sponsor entity, part of the Cactus Healthcare Management franchise. This is the only vehicle we have attributed to that sponsor.
Which banks underwrote the Cactus Acquisition Corp. 1 Ltd IPO?
Oppenheimer, Moelis. Oppenheimer and Moelis were credited as book-running managers on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Cactus Acquisition Corp. 1 Ltd a good investment?
That is not a question this site answers. Cactus Acquisition Corp. 1 Ltd is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Cactus Acquisition Corp. 1 Ltd data come from?
Filings Cactus Acquisition Corp. 1 Ltd submitted to the SEC under CIK 0001865861: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Sep 5, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Cactus Healthcare Management: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Oppenheimer in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Technology SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All liquidated spacs
Deadline lapsed without a deal; trust returned to public shareholders.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.